Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.
Living with lung cancer often means spending more time in waiting rooms than in the moments that matter. But that could ...
The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...
New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...
Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
12h
If you experience these symptoms repeatedly, you could have lung cancer: “You should see a doctor”
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...
Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...
The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...
Nearly 8% of Ohioans live with chronic obstructive pulmonary disease (COPD), a long-term, progressive lung disease that causes difficulty breathing. In fact, Ohio is among the states in the country ...
The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback